High Court Asked To Review Antitrust Standing Rule

Law360, New York (April 26, 2012, 8:17 PM EDT) -- SigmaPharm Inc. asked the U.S. Supreme Court last week to consider whether some of the circuits have improperly created a rule that only consumers and competitors involved in a market affected by anti-competitive behavior have standing to sue under U.S. antitrust law.

In a petition for a writ of certiorari filed April 20, the generic drug developer urged the justices to review a Third Circuit decision upholding the dismissal of its antitrust and contract suit against Mutual Pharmaceutical Co. Inc. and King Pharmaceuticals Inc. over royalties...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.